Covestro stock holds at EUR 45 as earnings recover

Published on 09/22/2026 at 13:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Covestro stock closed at EUR 45.00 on September 19, 2026, while Q2 EBITDA rose 13.7 percent year on year. Sales fell 2.0 percent.

Fotorealistisches Luftbild eines Polymerchemiewerks bei Dämmerung mit beleuchteter Industrieanlage — Covestro AG Chemiewerk DE0006062144 Leverkusen bei Nacht mit beleuchteten Reaktoren und Kühltürmen am Rhein, Illustration mit AI erstellt.

Covestro AG (ISIN DE0006062144) closed at EUR 45.00 on Xetra on September 19, 2026, with a market capitalization of EUR 8.5 billion. The latest reported quarter showed improving profitability, but weaker sales keep the recovery uneven.

EBITDA rises while sales fall

According to Ad-hoc-News on September 21, 2026, Covestro recorded group EBITDA of EUR 397 million in Q2 2026, up 13.7 percent from EUR 349 million in Q2 2025. Net income reached EUR 163 million, compared with EUR 111 million in the prior-year quarter, an increase of 46.8 percent.

The top line moved in the opposite direction. Q2 2026 sales were EUR 3.45 billion, down 2.0 percent from EUR 3.52 billion in Q2 2025, indicating that the earnings improvement came from profitability, costs and product mix rather than stronger revenue.

Guidance points to higher cash flow

Ad-hoc-News reported on September 21, 2026 that Covestro confirmed its full-year 2026 EBITDA guidance of EUR 1.3 billion to EUR 1.7 billion. The company also projected free operating cash flow between EUR 600 million and EUR 1.0 billion.

The guidance range puts execution at the center of the investment case. Q2 EBITDA improved by EUR 48 million year on year, yet quarterly sales declined by EUR 70 million. That contrast makes margins and cash generation more important than volume growth in the current reporting picture.

Stock remains inside its yearly range

Covestro stock closed at EUR 45.00 on Xetra at 5:39 p.m. on September 19, 2026. The quote remained within the documented 52-week range, while the EUR 8.5 billion market value gives the market a direct reference for the recovery implied by the 2026 guidance.

The central counter-factor is visible in the latest figures: selling prices and energy costs remained challenging even as EBITDA and net income increased. For investors, the key test is whether the improvement in earnings can continue without a renewed decline in sales.